Otonomy Inc. Closes Series B Financing Round At $38.5 Million
San Diego, Calif.-based Otonomy Inc. raised $38.5 million via a Series B financing. The round was co-led by Novo Ventures and RiverVest Venture Partners, and joined by Domain Associates and TPG Biotech. The clinical-stage biopharmaceutical concern previously raised around $10 million in Series A funding with Avalon Ventures in June 2010. Avalon participated in the latest round.
30 August 2010•3 mins read
